Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Looking at How the Rapid Adoption of Medical Weight Loss (MWL) Treatments is Changing Patient Behavior and Treatment Demand from Allergan and the Aesthetics Industry

Ticker(s): ABBV, RVNC, EOLS, SUPN, LLY, NVO, Galderma, Merz Pharma

Who's the expert?

Institution: NicholsMD of Greenwich

Board-certified dermatologist and cosmetic surgeon and founder and director of NicholsMD
Manages 1900 patients for obesity and medical weight management
Completed her dermatology residency at King-Drew/Harbor-UCLA Medical Center, where she served as Chief Resident; Research interests primarily on the intersection of medical dermatology and cosmetic innovation

Interview Goal

This call will focus on the topic of GLP-1 Medications Use for Weight Loss and the potential impact on aesthetic products from AbbVie/Allergan Aesthetics and other companies in the industry

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.